We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $95.5B
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
+8.8%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$83B
AUM Growth
+$4.08B
Cap. Flow
-$2.07B
Cap. Flow %
-2.5%
Top 10 Hldgs %
13.18%
Holding
730
New
59
Increased
161
Reduced
398
Closed
45

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$433M
2
LOW icon
Lowe's Companies
LOW
+$277M
3
ORCL icon
Oracle
ORCL
+$226M
4
PGR icon
Progressive
PGR
+$220M
5
LVS icon
Las Vegas Sands
LVS
+$167M

Sector Composition

Rank Sector Weight
1 Financials 19.96%
2 Healthcare 15.3%
3 Industrials 15.12%
4 Technology 14.91%
5 Consumer Discretionary 11.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LEN icon
176
Lennar Class A
LEN
$20.4B
$147M 0.18%
1,304,895
-483,380
-27% -$49.4M
MOS icon
177
The Mosaic Company
MOS
$7.09B
$144M 0.17%
3,670,086
-2,111,197
-37% -$80.8M
CALY
178
Callaway Golf Company
CALY
$3.26B
$144M 0.17%
5,242,973
+110,967
+2% +$3.08M
GNTX icon
179
Gentex
GNTX
$4.88B
$140M 0.17%
4,011,122
-1,148,819
-22% -$40.8M
WTM icon
180
White Mountains Insurance
WTM
$5.47B
$140M 0.17%
137,836
-5,996
-4% -$6.33M
BRSL
181
Brightstar Lottery PLC
BRSL
$1.91B
$137M 0.17%
4,866,009
-2,096,125
-30% -$59.3M
KRC icon
182
Kilroy Realty
KRC
$4.58B
$136M 0.16%
2,041,801
-17,402
-0.8% -$1.19M
NVST icon
183
Envista
NVST
$4.28B
$135M 0.16%
2,997,185
+74,776
+3% +$3.08M
DRI icon
184
Darden Restaurants
DRI
$22.5B
$134M 0.16%
892,581
-5,793
-0.6% -$856K
GPK icon
185
Graphic Packaging
GPK
$3.26B
$131M 0.16%
6,709,443
+363,984
+6% +$7.28M
YELP icon
186
Yelp
YELP
$1.38B
$131M 0.16%
3,616,038
-29,171
-0.8% -$1.1M
CHNG
187
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$130M 0.16%
6,082,602
+933,892
+18% +$19.6M
ALLE icon
188
Allegion
ALLE
$13B
$129M 0.16%
975,715
-59,808
-6% -$7.83M
KSS icon
189
Kohl's
KSS
$2.03B
$127M 0.15%
2,576,241
-110,487
-4% -$5.65M
MIDD icon
190
Middleby
MIDD
$6.05B
$125M 0.15%
636,180
+627,944
+7,624% +$115M
ESNT icon
191
Essent Group
ESNT
$6.06B
$123M 0.15%
2,707,365
-15,799
-0.6% -$724K
LH icon
192
Labcorp
LH
$24.3B
$118M 0.14%
438,815
-3,439
-0.8% -$851K
L icon
193
Loews
L
$24.3B
$117M 0.14%
2,026,056
-120,125
-6% -$6.81M
LVS icon
194
Las Vegas Sands
LVS
$30.5B
$114M 0.14%
3,039,422
-4,351,825
-59% -$167M
JBL icon
195
Jabil
JBL
$32.8B
$114M 0.14%
1,625,794
-99,009
-6% -$6.26M
AEP icon
196
American Electric Power
AEP
$73.7B
$114M 0.14%
1,276,526
-9,376
-0.7% -$791K
AVY icon
197
Avery Dennison
AVY
$12.3B
$113M 0.14%
522,047
-5,018
-1% -$1.07M
BA icon
198
Boeing
BA
$165B
$110M 0.13%
546,400
-35,612
-6% -$7.52M
NGVT icon
199
Ingevity
NGVT
$2.55B
$104M 0.13%
1,453,029
-591,602
-29% -$45M
CRI icon
200
Carter's
CRI
$1.43B
$104M 0.12%
1,022,703
-265,725
-21% -$27.1M

Similar funds

Boston Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Boston Partners held 730 positions worth $83B, up 5.2% from $78.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Boston Partners's Q4 2021 filing shows 59 new, 161 increased, 398 reduced and 45 closed positions. Its largest new stake was Keurig Dr Pepper: 15,605,496 shares worth $575M. The largest sale was Pfizer, an estimated $433M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 22% a quarter earlier, followed by Healthcare and Industrials.

  • Boston Partners's largest Q4 2021 buy was Keurig Dr Pepper: 15,605,496 shares worth $575M.
  • Boston Partners added most to Fidelity National Information Services in Q4 2021, an estimated $353M increase.
  • Boston Partners's biggest Q4 2021 reduction was Pfizer, cutting an estimated $433M.
  • Boston Partners fully exited CyrusOne Inc Common Stock in Q4 2021, selling an estimated $137M.
  • Boston Partners's ten largest holdings make up 13% of its $83B portfolio in Q4 2021.
  • Boston Partners opened 59 new positions and closed 45 in Q4 2021.
  • Boston Partners's portfolio value rose 5.2% quarter-over-quarter to $83B.

Based on Boston Partners's 13F filing for Q4 2021, filed 4 Feb 2022.